Sun Pharma — full event log
Every event we have on file across every reporting year. The Data-by-year tab summarises the top 10 per year; this page shows them all.
← back to Data by year2024· 15 events
Conducted biodiversity risk assessment at 5 manufacturing locations using TNFD V0.4 framework.
sustainability_report p.71
Scope 3 Cat 1 (Purchased Goods) dropped from 236,932 to 115,140 tCO2e YoY — a 51% decrease. May reflect methodology change or scope reduction; merits verification.
sustainability_report p.60
Sun Pharma set a target to become a Net Zero Company by 2050.
sustainability_report p.38
Target to co-process 30% of hazardous waste by 2025. FY 2024-25 achieved 27%.
sustainability_report p.56
Sun Pharma has set a target to reduce absolute carbon emissions (Scope 1 + Scope 2) by 35% by 2030 against 2020 baseline (451,068 tCO2e). 21% reduction achieved by FY 2024-25.
sustainability_report
Set target to be water-positive by 2030. Already achieved 25% reduction in water consumption vs 2020 baseline (target was 10% by 2025).
sustainability_report p.39
Diversity target to achieve 30% female workforce by 2040, with 40% in management positions in revenue generating functions. Current: 18.59% total workforce.
sustainability_report p.74
DNV provided independent assurance on the ESG Overview FY 2024-25 in accordance with ISO/IEC 17029:2019.
sustainability_report p.88
41% of energy from renewable sources in FY 2024-25, up from 31% in FY 2021-22. Strategy includes captive hybrid wind+solar plant for Gujarat facilities, captive solar at Dewas, captive windmills at Maduranthakam, expanded solar rooftop at Mohali, Poanta Sahib, Sikkim, Guwahati, Romania, Baddi sites, and fuel-substitution from furnace oil/HSD to renewable biomass briquettes for steam generation. Projecting >50% renewable energy share by 2030.
sustainability_report p.59
Deployment of heat pumps for hot water (replacing steam), high-efficiency chillers with smart controls, IE3 motors, VFDs for part-load operations, energy-efficient blowers, compressors, pumps, motion-sensor lighting, and condensate recovery upgrades. Specific energy consumption reduced 7% YoY (12.68 → 11.76 GJ/Revenue Mn INR).
sustainability_report p.59
Largest Scope 3 category. Reported 115,140 tCO2e in FY 2024-25 (down from 236,932 tCO2e in FY 2023-24). Suppliers required to abide by Supplier & Third Party Code of Conduct including ESG requirements; 64 suppliers assessed via desk-based ESG audits in FY 2024-25.
sustainability_report p.84
Zero Liquid Discharge (ZLD) systems implemented at 18 manufacturing sites. 25% reduction in water consumption vs 2020 baseline; transitioning from groundwater to surface water at multiple sites; rainwater harvesting to recharge local aquifers. Target: water-positive by 2030.
sustainability_report p.62
Sun Pharma is exploring carbon offset projects to neutralize residual emissions. Biodiversity assessment identified opportunities for carbon sequestration through greenbelt conservation to address residual emissions. No specific volumes of durable removals (DAC/BECCS) disclosed.
sustainability_report p.70
Boiler fuel substitution from conventional furnace oil and high-speed diesel to renewable biomass briquettes for steam generation across most sites. This is the primary driver of Scope 1 decline from 75,970 tCO2e (FY22) to 38,729 tCO2e (FY25) — a ~49% reduction.
sustainability_report p.59
Scope 3 transport categories total ~44,000 tCO2e in FY 2024-25. Mitigation includes shifting from air to sea shipments where feasible, local sourcing to reduce long-haul logistics emissions, and eco-friendly reusable multi-layered cold storage packaging for one main product to reduce CO2 emissions in distribution.
sustainability_report p.86